Q4 2024 Medpace Holdings Inc Earnings Call Transcript

Feb 11, 2025 / 02:00PM GMT

Release Date Price: MXN7176

Transcript 10-K8-K

Key Points

Positve

Medpace Holdings Inc (MEDP) reported a 7.7% year-over-year increase in revenue for Q4 2024, reaching $536.6 million.
Full-year 2024 revenue grew by 11.8% compared to 2023, totaling $2.11 billion.
EBITDA for Q4 2024 increased by 39.3% year-over-year, reaching $133.5 million, with a margin improvement to 24.9%.
Net income for Q4 2024 rose by 49.5% compared to the previous year, amounting to $117 million.
The company has a strong cash position with $669.4 million in cash as of December 31, 2024, and generated $190.7 million in cash flow from operating activities in Q4 2024.

Negative

The book-to-bill ratio for Q4 2024 was 0.99, indicating a slight decline in new business awards.
Net new business awards for the full year 2024 decreased by 5.4% compared to the previous year.
The business environment showed signs of weakening in Q4 2024, with a slight decrease in RFPs compared to Q3.
Guidance for 2025 indicates flat to low single-digit revenue growth, reflecting challenges in the business environment.
Elevated cancellation rates in 2024 have impacted the backlog and may continue to affect bookings in the first half of 2025.

Operator

Good day, ladies and gentlemen, and welcome to the Medpace fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded.

And now I'd like to introduce your host for today's conference call, Lauren Morris, MedPace's Director of Investor Relations. You may begin.

Lauren Morris

Medpace Holdings Inc - Director - Investor Relations

Good morning, and thank you for joining MedPace's fourth-quarter and full-year 2024 earnings conference call. Also on the call today is our CEO, August Troendle; our President, Jesse Geiger; and our CFO, Kevin Brady.

Before we begin, I would like to remind you that our remarks and responses to your questions during this teleconference may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve inherent assumptions with known and unknown risks and uncertainties, as well as other important factors that could cause actual results to differ materially from our current

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.